Thank you, operator, and good morning, everyone.
Thank you for joining the Harvard Bioscience Third Quarter 2025 Earnings Conference Call. Leading the call today will be John Duke, President and Chief Executive Officer; and Mark Frost, Interim Chief Financial Officer.
In conjunction with today’s recorded call, we have provided a presentation that will be referenced during our remarks. This presentation is posted in the Investor Relations section of our website at investor.harvardbioscience.com.
Please note that statements made in today’s discussion that are not historical facts, including statements on management’s expectations of future events or future financial performance, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements reflect the current views of Harvard Bioscience’s management. Harvard Bioscience assumes no obligation to update or revise any forward-looking statements. Actual results may differ materially from those expressed or implied.
We encourage you to refer to today’s press release, the Harvard Bioscience Form 10-Q, and other filings with the Securities and Exchange Commission for additional disclosures on forward-looking statements as well as the risks, uncertainties, and contingencies associated therewith.
During the call, management will also reference certain non-GAAP measures.
https://seekingalpha.com/article/4840048-harvard-bioscience-inc-hbio-q3-2025-earnings-call-transcript?source=feed_all_articles